Last updated on November 2018

Randomized, Double-Blind, Placebo-Controlled, 2-Arm, 6-Month, Brain Imaging and Safety Study of TRx0237 in Subjects With Mild Alzheimer's Disease


Brief description of study

The purpose of this study is to determine the safety and efficacy of TRx0237 8 mg/day in the treatment of subjects with mild Alzheimer's Disease compared to placebo.

Clinical Study Identifier: TX205748

Find a site near you

Start Over

NeuroStudies

2665 N. Decatur Rd. Suite 740 Decatur, GA United States
  Connect »